Bacterial-Derived Polyhydroxyalkanoate/Bioceramic Composites in Clinical Practice: State of the Art and Future Perspectives

细菌来源的聚羟基烷酸酯/生物陶瓷复合材料在临床实践中的应用:现状与展望

阅读:2

Abstract

This review examines the current advancements in and potential of bioceramic/polyhydroxyalkanoate (BioC/PHA) composites, emphasizing their growing role in biomedical applications. The integration of PHAs─biodegradable, biocompatible polymers from a bacterial origin─with bioceramics like hydroxyapatite or bioglass offers a unique synergy, combining the structural integrity of ceramics with the tunable properties of PHAs. Such composites demonstrate significant promise in bone tissue engineering, cartilage repair, and drug delivery systems, where they support cell attachment, proliferation, and targeted therapeutic release. The review highlights various methods of manufacturing these composites. Additionally, the review addresses challenges in production scalability, cost, and material purification necessary to meet medical-grade standards. Advances in functionalization, such as drug incorporation and bioactive coatings, are discussed as pathways to customized therapeutic solutions. This review underscores the transformative potential of BioC/PHA composites in creating sustainable, multifunctional biomaterials that align with the clinical demands of regenerative medicine and environmentally conscious material science.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。